Send to

Choose Destination
Autophagy. 2019 Mar 1:1-11. doi: 10.1080/15548627.2019.1586249. [Epub ahead of print]

Down-regulated TMED10 in Alzheimer disease induces autophagy via ATG4B activation.

Author information

a School of Life Sciences , Kyungpook National University , Daegu , Republic of Korea.
b Department of Gerontology , Graduate School of E-W Medical Science, Kyung Hee University , Yongin , South Korea.
c Asan Institute for Life Sciences , Asan Medical Center , Seoul , South Korea.
d College of Life Sciences and Nanotechnology , Hannam University , Daejeon , South Korea.
e School of Pharmacy , Sungkyunkwan University , Suwon , South Korea.
f Department of Surgery , University of Ulsan College of Medicine, Asan Medical Center , Seoul , South Korea.
g School of Biological Sciences , Seoul National University , Seoul , South Korea.
h Department of Neurology , University of Ulsan College of Medicine, Asan Medical Center , Seoul , South Korea.


Several studies have shown that dysfunction of macroautophagy/autophagy is associated with many human diseases, including neurodegenerative disease and cancer. To explore the molecular mechanisms of autophagy, we performed a cell-based functional screening with SH-SY5Y cells stably expressing GFP-LC3, using an siRNA library and identified TMED10 (transmembrane p24 trafficking protein 10), previously known as the γ-secretase-modulating protein, as a novel regulator of autophagy. Further investigations revealed that depletion of TMED10 induced the activation of autophagy. Interestingly, protein-protein interaction assays showed that TMED10 directly binds to ATG4B (autophagy related gene 4B cysteine peptidase), and the interaction is diminished under autophagy activation conditions such as rapamycin treatment and serum deprivation. In addition, inhibition of TMED10 significantly enhanced the proteolytic activity of ATG4B for LC3 cleavage. Importantly, the expression of TMED10 in AD (Alzheimer disease) patients was considerably decreased, and downregulation of TMED10 increased amyloid-β (Aβ) production. Treatment with Aβ increased ATG4B proteolytic activity as well as dissociation of TMED10 and ATG4B. Taken together, our results suggest that the AD-associated protein TMED10 negatively regulates autophagy by inhibiting ATG4B activity.Abbreviations: Aβ: amyloid-β; AD: Alzheimer disease; ATG: autophagy related; BECN1: beclin 1; BiFC: bimolecular fluorescence complementation; CD: cytosolic domain; GFP: green fluorescent protein; GLUC: Gaussia luciferase; IP: immunoprecipitation; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; LD: luminal domain; PD: Parkinson disease; ROS: reactive oxygen species; siRNA: small interfering RNA; SNP: single-nucleotide polymorphisms; TD: transmembrane domain; TMED10: transmembrane p24 trafficking protein 10; VC: C terminus of Venus fluorescent protein; VN: N terminus of Venus fluorescent protein.


ATG4B; Alzheimer disease; TMED10; autophagy; screening

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center